Myriad - M&A Summary and Business Overview

Life ScienceCompany

Myriad M&A Summary

Myriad has acquired 6 companies, including 1 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 4 assets.

Myriad’s largest acquisition to date was in 2018, when it acquired Counsyl for $375M. It’s largest disclosed sale occurred in 2021, when it sold Myriad Autoimmune s Vectra Testing Business to Laboratory of America Holdings for $150M. Myriad has acquired in 4 different US states, and 2 countries. The Company’s most targeted sectors include life science (84%) and medical products (17%).

Myriad Business Overview

Where is Myriad headquartered?

Myriad is headquartered in Salt Lake City, Utah.

What is Myriad’s revenue?

Myriad disclosed revenue of 753M USD for 2023 and 678M USD for 2022.

How many employees does Myriad have?

Myriad has 2,700 employees.

What sector is Myriad in?

Myriad is a life science company.

When was Myriad founded?

Myriad was founded in 1991.

M&A Summary

  • M&A Total Activity10
    • M&A Buy Activity6
    • M&A Sell Activity4
  • Total Sectors Invested 2
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 6
  • M&A Advisors 6

Myriad

Myriad Genetics, Inc.

322 North 2200 West,
Salt Lake City, Utah 84116
United States,
(801) 584-3600
www.myriad.com

Myriad is a molecular diagnostic company discovers and commercialize a transformative tests to assess a person's risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence. Myriad was founded in 1991 and is based in Salt Lake City, Utah.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # 5 - - - - 1 6
vol $989M $989M
Sell (0.8/yr) # - - 4 - - - 4
vol $215M $215M
  10

Most Recent M&A

Company Date Value Type
Myriad Genetics - EndoPredict Business 2024-05-07 - Divestiture
Salt Lake City, Utah
Myriad RBM, Inc. 2021-05-24 - Divestiture
Austin, Texas · www.myriadrbm.com
Myriad Autoimmune's Vectra Testing Business 2021-05-03 150M USD Divestiture
Salt Lake City, Utah
Myriad myPath Melanoma LLC 2021-04-27 33M USD Divestiture
Salt Lake City, Utah
myPath LLC 2021-04-27 33M USD Divestiture
Salt Lake City, Utah · myriad.com
Counsyl, Inc. 2018-05-28 375M USD Add-on Acquisition
South San Francisco, California · www.counsyl.com
Assurex Health, Inc. 2016-08-03 225M USD Add-on Acquisition
Mason, Ohio · www.assurexhealth.com
Sividon Diagnostics GmbH 2016-05-31 39M EUR Add-on Acquisition
Cologne, Germany · www.­sividon.­com
Crescendo Bioscience, Inc. 2014-02-04 270M USD Divestiture
South San Francisco, California · www.crescendobio.com
Rules-Based Medicine (RBM) 2011-06-01 80M USD Add-on Acquisition
Austin, Texas
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 5 (83%) 950M (96%) 2 (50%) 33M (15%)
Medical Products 1 (17%) 39M (4%) - -
Healthcare Services - - 1 (25%) 33M (15%)
Test/Measurement Equipment - - 1 (25%) 150M (70%)
Total 6 $989M 4 $215M

By Geo

State/Country Buy Value Sell Value
United States 5 950M 4 215M
  Utah 1 - 3 215M
  California 2 645M - -
  Texas 1 80M 1 -
  Ohio 1 225M - -
Germany 1 39M - -
Domestic 5 (83%) 950M (96%) 4 (100%) 215M (100%)
Cross-border 1 (17%) 39M (4%) - -
Total 6 $989M 4 $215M

Top M&A Advisors

Financial Deals
J.P. Morgan Securities
2
Cowen Group, Inc.
1
Guggenheim Securities
1
Legal Deals
Mintz Levin Cohn Ferris Glovsky and Popeo PC
4
Katten Muchin Rosenman
1

Deal Values

buy # Total
$100M to $1B 3 $870M
< $100M 2 $119M
TOTAL $989M
Largest Counsyl, Inc.
$375M (2018-05-28)
sell # Total
$100M to $1B 1 $150M
< $100M 2 $65M
TOTAL $215M
Largest Myriad Autoimmune's Vectra Testing Business
$150M (2021-05-03)

M&A Connections

Deals
Acquired from
Investor(s)
17%
1 (17%)
Strategic(s)
33%
2 (33%)
Divested to
Strategic(s)
100%
4 (100%)

 Subscribe to unlock this and 206,758
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.